CDN1163
≥99%
- Product Code: 67320
CAS:
892711-75-0
| Molecular Weight: | 320.39 g./mol | Molecular Formula: | C₂₀H₂₀N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
CDN1163 is primarily researched for its potential therapeutic applications in the treatment of metabolic disorders, particularly type 2 diabetes. It functions as an allosteric activator of the sarco/endoplasmic reticulum calcium ATPase (SERCA), which plays a critical role in calcium homeostasis within cells. By enhancing SERCA activity, CDN1163 helps improve insulin sensitivity and glucose metabolism, making it a promising candidate for managing diabetes. Additionally, its ability to regulate calcium signaling may have broader implications in addressing other conditions linked to calcium dysregulation, such as cardiovascular diseases and neurodegenerative disorders. Ongoing studies aim to further explore its efficacy and safety for clinical use.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white solid |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿8,170.00 |
+
-
|
| 0.010 | 10-20 days | ฿13,360.00 |
+
-
|
CDN1163
CDN1163 is primarily researched for its potential therapeutic applications in the treatment of metabolic disorders, particularly type 2 diabetes. It functions as an allosteric activator of the sarco/endoplasmic reticulum calcium ATPase (SERCA), which plays a critical role in calcium homeostasis within cells. By enhancing SERCA activity, CDN1163 helps improve insulin sensitivity and glucose metabolism, making it a promising candidate for managing diabetes. Additionally, its ability to regulate calcium signaling may have broader implications in addressing other conditions linked to calcium dysregulation, such as cardiovascular diseases and neurodegenerative disorders. Ongoing studies aim to further explore its efficacy and safety for clinical use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :